The future of infectious disease diagnostics starts at Day Zero. By using whole-genome sequencing (WGS) and the proprietary enabling technologies, Day Zero is creating a new class of sequencing-based in-vitro diagnostics that generates clinically actionable data at scale.

Medical Devices

Day Zero Diagnostics

Day Zero Diagnostics' headquarters in Boston, MA, United States

This department provides strategic direction and decision-making to guide the organization.

Leadership Council

The Leadership Team at Day Zero Diagnostics drives the company's strategic vision and operational excellence in the development of innovative infectious disease diagnostics. Comprising co-founders and senior executives with expertise in business development, scientific research, and medical affairs, this team collaborates to advance whole-genome sequencing technologies and ensure the delivery of clinically actionable data to improve patient outcomes. Their collective leadership shapes the company’s direction, fosters partnerships, and oversees product realization and commercialization efforts.

Leadership Team

The Clinical and Scientific Advisors at Day Zero Diagnostics play a crucial role in bridging the gap between advanced genomic technology and clinical application. This team provides expertise in scientific research, regulatory compliance, and clinical strategies, ensuring that the company’s innovative sequencing-based diagnostic solutions are not only effective but also aligned with industry standards and patient needs. They collaborate closely with various departments to support the development and implementation of cutting-edge diagnostics that deliver actionable insights for infectious disease management.

Clinical and Scientific Advisors

The Research and Development team at Day Zero Diagnostics is dedicated to innovating and enhancing next-generation sequencing techniques for infectious disease diagnostics. This team conducts advanced research in molecular biology, computational analysis, and machine learning to develop and validate new diagnostic assays. By integrating cutting-edge technologies and interdisciplinary expertise, they aim to produce scalable, clinically actionable data that can transform patient care in infectious diseases.

Research and Development

The Engineering Team at Day Zero Diagnostics is responsible for designing and developing cutting-edge technologies that enhance the capabilities of infectious disease diagnostics. This team collaborates on projects ranging from infrastructure optimization and software development to mechanical design and systems engineering, ensuring that the innovative applications of whole-genome sequencing deliver clinically actionable insights with precision and efficiency.

Engineering Team

The Product and Strategy Team at Day Zero Diagnostics is responsible for driving the development and market introduction of innovative sequencing-based diagnostic products. They collaborate across functions to align business goals with product realization, ensuring that emerging technologies translate into clinically actionable solutions. This team also engages with stakeholders to refine market strategies and enhance communication of product benefits, ultimately advancing the company's mission in infectious disease diagnostics.

��

People (3)

Jobs (0)

Other teams

Leadership Team

Clinical and Scientific Advisors

Research and Development

Engineering Team

Product and Strategy Team

��������

People (3)

Jobs (0)

Other teams

Leadership Team

Clinical and Scientific Advisors

Research and Development

Engineering Team

Product and Strategy Team

��